Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Statement of problem: Although over the last fifteen years, the prevalence of malaria became reduced by over half but developing
resistance against artemisinin derivatives and its combinations, which are the only ray of hope to treat resistant malaria set back the
control efforts and the key hindrance to achieve the goal of malaria elimination till 2030. In spite these artemisinins are precious
antimalarials, their action mechanism is yet to be fully understood. Reactive oxygen species (ROS) produces by cleavage of
endoperoxide bridge of artemisinin derivatives are known to be its antimalarial efficacy. Since ROS could induce apoptosis, here we
had explored the effect of artemisinin derivatives on the apoptotic machinery of the malaria parasite, Plasmodium falciparum, and
its survival.
Methodology: The effect of α/β arteether, artesunate and a synthetic 1,2,4 trioxanes was studied on the apoptotic machinery of
asexual blood stages of Plasmodium falciparum 3D7. We have evaluated the hallmark marker of the apoptotic pathway; disturbance
in mitochondrial membrane potential, caspase activation and in situ DNA fragmentation.
Findings: Results have shown that cleavage of peroxide bridge of artemisinin derivatives and 1,2,4 trioxane generate reactive oxygen
species which depolarize mitochondrial membrane potential and make it permeable which further followed by downstream events
of apoptotic cell death like activation of the caspase-like enzyme and DNA fragmentation.
Conclusion and significance: The results suggested that artemisinin derivatives and synthetic trioxane induce apoptosis in the
erythrocytic stage of malaria parasite: Plasmodium falciparum. Since Plasmodium has metacaspase at the place of caspases, which are
found in human, it could be exploited as the new therapeutic target for malaria.